James Chen, Ph.D.

Assistant Professor of Medicine


BE, Biochemistry
East China Institute of Chemical Technology
Shanghai, China

PhD, Biochemistry and Molecular Biology
Louisiana State University Medical Center
New Orleans, Louisiana

Postgraduate Training

Post-doctoral Fellowship, Multiple Myeloma
University of Arkansas for Medical Sciences
Little Rock, Arkansas

Post-doctoral Fellowship
National Center for Toxicological Research
Jefferson, Arkansas

Current Research

Dr. Chen’s research focuses on the identification and validation of bone marrow serum exosome miRNA signatures for better classification and prognostication of myeloma. He is conducting and developing molecular biology assays in order to assess and validate molecular variables associated with risk assessment of plasma cell dyscrasias, prediction of survival and progression-free survival, and progression from predecessor stages of MGUS and smoldering myeloma to active myeloma requiring therapy. Dr. Chen is also adapting the Fluidigm Biomark for analyzing copy number variation and mutational analysis on single cells following processing by the Fluidgm C1 in order to determine changes in clonal heterogeneity following therapy.


Contact Information

Email: ChenBangzheng@uams.edu